PPA
GTHX

Parametric Portfolio Associates’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

Parametric Portfolio Associates’s Portfolio GTHX Stock Details GTHX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$119K Sell
15,701
-10,340
-40% -$98.1K ﹤0.01% 3538
2021
Q4 		$266K Sell
26,041
-47,764
-65% -$609K ﹤0.01% 3321
2021
Q3 		$990K Buy
73,805
+45,376
+160% +$739K ﹤0.01% 2810
2021
Q2 		$624K Buy
28,429
+1,852
+7% +$41.1K ﹤0.01% 2993
2021
Q1 		$639K Buy
26,577
+10,486
+65% +$244K ﹤0.01% 3380
2020
Q4 		$289K Sell
16,091
-23,006
-59% -$344K ﹤0.01% 3615
2020
Q3 		$452K Sell
39,097
-544
-1% -$8.98K ﹤0.01% 3323
2020
Q2 		$962K Buy
39,641
+2,355
+6% +$38.9K ﹤0.01% 2939
2020
Q1 		$411K Buy
37,286
+22,694
+156% +$424K ﹤0.01% 3269
2019
Q4 		$386K Sell
14,592
-29,214
-67% -$683K ﹤0.01% 3468
2019
Q3 		$998K Buy
43,806
+30,577
+231% +$964K ﹤0.01% 3029
2019
Q2 		$406K Buy
+13,229
New +$279K ﹤0.01% 3460
2018
Q2 		– Sell
-38,374
Closed -$1.42M – 3949
2018
Q1 		$1.42M Buy
+38,374
New +$1.02M ﹤0.01% 2815

Other funds holding GTHX

State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
LOAMS
Lombard Odier Asset Management (Switzerland) Petit-Lancy, Switzerland $3.14B AUM 46.44% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

Parametric Portfolio Associates's GTHX Position: Q1 2022 in Review

Parametric Portfolio Associates reduced its G1 Therapeutics, Inc. Common Stock (GTHX) stake by 40% in Q1 2022, selling an estimated $98.1K and leaving 15,701 shares worth $119K. The position accounts for ﹤0.01% of the portfolio, ranked #3538.

Parametric Portfolio Associates first reported a position in GTHX in Q1 2018 and has held it in 13 quarters since. The position peaked at $1.42M in Q1 2018. 115 funds tracked by Wall St. Rank hold GTHX as of Q1 2022.

  • Parametric Portfolio Associates held 15,701 shares of G1 Therapeutics, Inc. Common Stock worth $119K as of Q1 2022.
  • Parametric Portfolio Associates sold 10,340 G1 Therapeutics, Inc. Common Stock shares in Q1 2022, an estimated $98.1K.
  • G1 Therapeutics, Inc. Common Stock made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #3538 holding.
  • Parametric Portfolio Associates first reported a position in G1 Therapeutics, Inc. Common Stock in Q1 2018 and has held it in 13 quarters since.
  • Parametric Portfolio Associates's G1 Therapeutics, Inc. Common Stock position peaked at $1.42M in Q1 2018.
  • 115 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.